Tableau de bord de la cohorte

La mission du GP2 est de mieux comprendre l’architecture génétique de la maladie de Parkinson (MP) par le génotypage de groupes de patients différents et l’étude des formes soulevant une forte suspicion de cause monogénique de la MP. En soutien à cette mission, nous constituons des cohortes différentes dans le monde en collaborant et en partageant ouvertement les données, les processus et les résultats. Le tableau de bord ci-dessous présente les étapes que nous avons franchies jusqu’à présent. Consultez régulièrement cette page car les données sont mises à jour sur une base trimestrielle.

Total des données mondiales

0
Emplacements uniques
0
Cohortes
0
Echantillons prévus
0
Echantillons terminés

Last Updated: August 10, 2022 | Original design by GP2 Hackathon 2021 Team: Mary Makarious, Kajsa Brolin, Yeajin Song, and Anastasia Illarionova.

Showing 50 of 200 cohort studies.

“Finding the Gene” study

Te Whatu Ora - Health New Zealand | Auckland, New Zealand
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

ADepT-PD

University College London | London, United Kingdom
Number of Samples Completed and Expected
Case Samples
0 Completed out of 408 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 408 Expected

AGPDS

QIMR Berghofer Medical Research Institute | Brisbane, Australia
Number of Samples Completed and Expected
Case Samples
0 Completed out of 5,000 Expected
Control Samples
0 Completed out of 5,000 Expected
Total Samples
0 Completed out of 10,000 Expected

ANANEOS Study

Ionian University, Altoida Inc. | Corfu, Greece
Number of Samples Completed and Expected
Case Samples
0 Completed out of 300 Expected
Control Samples
0 Completed out of 300 Expected
Total Samples
0 Completed out of 600 Expected

Arizona Brain Bank Brain and body donation programme (BBDP)

Banner Sun Health Research Institution | Pheonix, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 324 Expected
Control Samples
0 Completed out of 100 Expected
Total Samples
0 Completed out of 424 Expected

AUTH – GP2 study

Aristotle University of Thessaloniki | Thessaloniki, Greece
Number of Samples Completed and Expected
Case Samples
0 Completed out of 100 Expected
Control Samples
0 Completed out of 60 Expected
Total Samples
0 Completed out of 160 Expected

BADGE-PD

Assistance Publique Hôspitaux de Paris | Paris, France
Number of Samples Completed and Expected
Case Samples
0 Completed out of 304 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 304 Expected

Baylor College of Medicine (BCM)

Baylor College of Medicine | Houston, United States
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
533 Completed out of 553 Expected
Control Samples
246 Completed out of 255 Expected
Total Samples
779 Completed out of 808 Expected
Ancestry Breakdown for Samples Completed
Show

BCM-UMD

University of Maryland | College Park, United States
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
358 Completed out of 358 Expected
Control Samples
83 Completed out of 83 Expected
Total Samples
441 Completed out of 441 Expected
Ancestry Breakdown for Samples Completed
Show

BERN

Inselspital Bern | Bern, Switzerland
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

BioFIND

Michael J. Fox Foundation | New York City, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 220 Expected
Control Samples
0 Completed out of 100 Expected
Total Samples
0 Completed out of 320 Expected

Biological markers in PD

National and Kapodistrian University of Athens | Athens, Greece
Number of Samples Completed and Expected
Case Samples
0 Completed out of 350 Expected
Control Samples
0 Completed out of 150 Expected
Total Samples
0 Completed out of 500 Expected

BLAAC-PD – Kaiser Permanente

Kaiser Permanente | Rockville, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 125 Expected
Control Samples
0 Completed out of 125 Expected
Total Samples
0 Completed out of 250 Expected

BLAAC-PD – Rush University

Rush University | Chicago, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 100 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 100 Expected

BLAAC-PD – University of Alabama at Birmingham

University of Alabama at Birmingham | Birmingham, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 50 Expected
Control Samples
0 Completed out of 50 Expected
Total Samples
0 Completed out of 100 Expected

BLAAC-PD – University of Chicago

University of Chicago | Chicago, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 100 Expected
Control Samples
0 Completed out of 50 Expected
Total Samples
0 Completed out of 150 Expected

C-OPD

University of Calgary/McGill University | Calgary, Canada
Number of Samples Completed and Expected
Case Samples
0 Completed out of 1,500 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 1,500 Expected

CALYPSO

University College London | London, United Kingdom
Number of Samples Completed and Expected
Case Samples
0 Completed out of 400 Expected
Control Samples
0 Completed out of 200 Expected
Total Samples
0 Completed out of 600 Expected

Cambridge Parkinson’s Research Clinic

University of Cambridge | Cambridge, United Kingdom
Number of Samples Completed and Expected
Case Samples
0 Completed out of 250 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 250 Expected

CamPaIGN

University of Cambridge | Cambridge, United Kingdom
Number of Samples Completed and Expected
Case Samples
0 Completed out of 142 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 142 Expected

CANDAS

University College London | London, United Kingdom
Number of Samples Completed and Expected
Case Samples
0 Completed out of 244 Expected
Control Samples
0 Completed out of 18 Expected
Total Samples
0 Completed out of 262 Expected

Central Asian and Transcaucasian PD (CAT-PD)

University College London | Almaty, Kazakhstan
Number of Samples Completed and Expected
Case Samples
0 Completed out of 200 Expected
Control Samples
0 Completed out of 200 Expected
Total Samples
0 Completed out of 400 Expected

Central Asian and Transcaucasian PD (CAT-PD) – Avicena Tajik State Medical University

Avicena Tajik State Medical University | Dushanbe, Tajikistan
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

Central Asian and Transcaucasian PD (CAT-PD) – Istanbul Klinic

Istanbul Klinic | Baku, Azerbaijan
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

Central Asian and Transcaucasian PD (CAT-PD) – Kazakh National Medical University

Kazakh National Medical University | Almaty, Kazakhstan
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

Central Asian and Transcaucasian PD (CAT-PD) – Somnus Movement Disorders Clinic

Somnus Movement Disorders Clinic | Yerevan, Armenia
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

Central Asian and Transcaucasian PD (CAT-PD) – Tbilisi State Medical University

Tbilisi State Medical University | Tbilisi, Georgia
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

Central Asian and Transcaucasian PD (CAT-PD) -South Kazakhstan Medical Academy

South Kazakhstan Medical Academy | Shymkent, Kazakhstan
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

Christchurch Longitudinal Parkinson’s Study

Southern Health and Disability Ethics Committee | Larissa, Greece
Number of Samples Completed and Expected
Case Samples
0 Completed out of 350 Expected
Control Samples
0 Completed out of 80 Expected
Total Samples
0 Completed out of 430 Expected

Clinical and genetic study of Unusual/Familial Movement Disorders

University of Cincinnati | Cincinnati, United States
Number of Samples Completed and Expected
Case Samples
0 Completed out of 500 Expected
Control Samples
0 Completed out of 180 Expected
Total Samples
0 Completed out of 680 Expected

Clinicogenetic study of PD in Tunisia

National Institute of Neurology Mongi-Ben Hamida | Tunis, Tunisia
Number of Samples Completed and Expected
Case Samples
0 Completed out of 150 Expected
Control Samples
0 Completed out of 150 Expected
Total Samples
0 Completed out of 300 Expected

CORIELL

CORIELL | Camden, United States
Access Data on AMP® PD
Number of Samples Completed and Expected
Case Samples
4,152 Completed out of 4,478 Expected
Control Samples
2,883 Completed out of 4,111 Expected
Total Samples
7,035 Completed out of 8,589 Expected
Ancestry Breakdown for Samples Completed
Show

CSF Biomarkers

University of Perugia | Perugia, Italy
Number of Samples Completed and Expected
Case Samples
0 Completed out of 60 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 60 Expected

DATATOP

Michael J. Fox Foundation | Rochester, United States
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

DeNoPa

University of Göttingen | Goettingen, Germany
Number of Samples Completed and Expected
Case Samples
0 Completed out of 140 Expected
Control Samples
0 Completed out of 100 Expected
Total Samples
0 Completed out of 240 Expected

DIGPD

Assistance Publique Hôspitaux de Paris | Paris, France
Number of Samples Completed and Expected
Case Samples
0 Completed out of 400 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 400 Expected

ELPD Project

Queen Mary University London | London, United Kingdom
Number of Samples Completed and Expected
Case Samples
0 Completed out of 300 Expected
Control Samples
0 Completed out of 250 Expected
Total Samples
0 Completed out of 550 Expected

Familial and early-onset PD Database

University "Magna Graecia" of Catanzaro | Catanzaro, Italy
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

Families with neurodegenerative diseases

Medical University of Vienna | Vienna, Austria
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

GeneFinder

Hannover Medical School | Cairo, Egypt
Number of Samples Completed and Expected
Case Samples
0 Completed out of 420 Expected
Control Samples
0 Completed out of 450 Expected
Total Samples
0 Completed out of 870 Expected

GenePARKGR

University of Thessaly, Medical School | Volos, Greece
Number of Samples Completed and Expected
Case Samples
0 Completed out of 586 Expected
Control Samples
0 Completed out of 469 Expected
Total Samples
0 Completed out of 1,055 Expected

Genetic analysis in inherited neurological disorders

Garvan Institute of Medical Research | Sydney, Australia
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

Genetic study of PD and related movement disorders

Stellenbosch University | Cape Town, South Africa
Number of Samples Completed and Expected
Case Samples
0 Completed out of 730 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 730 Expected

Genetic Testing in Patients with Movement Disorders and PD

Chulalongkorn University | Bangkok, Thailand
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

Genomes Project

University College London | London, United Kingdom
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

Genomewide Association Study in PD among East Asians

National Taiwan University Hospital | Taipei City, Taiwan
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

Genotype-Phenotype Correlations in Nepalese PD Population

Tribhuvan University | Kathmandu, Nepal
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

Genotype-Phenotype Correlations in PD and Related Movement Disorders

University of Malaysia | Kuala Lumpur, Malaysia
Number of Samples Completed and Expected
Case Samples
Pending
Control Samples
Pending
Total Samples
Pending

GP2 – Fundación Diagnosis

Fundación Diagnosis | Santiago, Chile
Number of Samples Completed and Expected
Case Samples
0 Completed out of 100 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 100 Expected

GP2 – Koc University

Koc University | Istanbul, Turkey
Number of Samples Completed and Expected
Case Samples
0 Completed out of 200 Expected
Control Samples
0 Completed out of 0 Expected
Total Samples
0 Completed out of 200 Expected

Demande d’ensemble de données auprès de l’AMP-PD

Une fois que le GP2 a terminé le génotypage d’une cohorte, l’intégralité des données est partagée par le biais de la plateforme sécurisée AMP® PD. Il est obligatoire de s’inscrire pour demander l’accès aux données.

Soumettre une cohorte

Si vous souhaitez collaborer avec l’équipe du GP2, veuillez nous contacter pour soumettre une cohorte ou obtenir de plus amples renseignements sur la procédure à suivre pour devenir membre.

Rencontrez les membres du GP2 du monde entier

Découvrez les membres de notre organisation dont la contribution, notamment en termes d’échantillons et de données, nous permet de poursuivre nos travaux de recherche.